🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Spain / NCT07661836
Active, not recruiting Not applicable

Personalized Online Occupational Therapy Intervention for Adults With Scleroderma

NCT07661836 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2026-05-16
Last updated
2026-06-22

Condition(s) studied

SclerodermaScleroderma (Limited and Diffuse)Systemic Sclerosis (SSc)

Investigational drug(s) / intervention(s)

Personalized Online Occupational Therapy InterventionUsual Care

Personalized Online Occupational Therapy Intervention: The intervention consists of eight individual online occupational therapy sessions delivered over four weeks, with two sessions per week, through videoconference and without recording. Sessions are individualized according to baseline assessment, participant needs, and personalized occupational goals. The intervention may include goal setting using SMART criteria and Goal Attainment Scaling, hand preparation for occupation, self-care and pain management strategies, energy conservation, daily planning, environmental adaptations, assistive product guidance, occupational balance strategies, functional integration, and a maintenance plan. The intervention is delivered in addition to usual care.

Usual Care: Usual care refers to the ordinary health and social care that participants receive in their usual context. It is not administered by the research team. Participants allocated to this arm will not receive additional occupational therapy from the research team during the intervention and follow-up period. Changes in usual care will be recorded at post-intervention and follow-up assessments.

Study summary

This pilot exploratory randomized controlled trial will evaluate the feasibility, acceptability, and safety of a personalized online occupational therapy intervention for adults with scleroderma in Spain. Participants will be individually randomized in a 1:1 ratio to either an online occupational therapy intervention added to usual care or usual care alone. The intervention consists of eight individual online occupational therapy sessions delivered over four weeks, with two sessions per week, plus individualized materials. The control group will continue with usual care during the intervention and follow-up period. Outcomes will be assessed at baseline, post-intervention, and four weeks after the end of the intervention. The primary outcome is feasibility, defined as the proportion of participants in the intervention group who complete at least six of the eight planned sessions. Secondary and exploratory outcomes include acceptability, adherence, safety, technical feasibility, functioning, quality of life, occupational balance, hand function, and individual goal attainment.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults aged 18 years or older with scleroderma from the previous project cohort and meeting the general eligibility criteria of the initial study. * Current residence in Spain. * Sufficient Spanish language ability to provide informed consent, participate in the intervention, and complete study assessments. * Ability to understand the study information and provide informed consent, with support if needed. * Access to the internet and to a device compatible with Google Meet and Hefora. * Availability to participate in eight online sessions of approximately 60 minutes, twice weekly over four weeks. * Not currently participating in a specific occupational therapy program or another intervention that could substantially influence functioning, activities of daily living, quality of life, or occupational balance. * Provision of informed consent and completion of the baseline assessment. Exclusion Criteria: * Clinical condition or severe comorbidity preventing safe participation. * Current residence outside Spain. * Inability to provide informed consent or complete the baseline assessment. * Concurrent participation in a specific occupational therapy program or another intensive, potentially interfering rehabilitation or therapeutic education intervention. * Withdrawal of interest before the effective start of the intervention or inability to participate during the planned study dates.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Universidad de Zaragoza Zaragoza Zaragoza / Aragón

More Universidad de Zaragoza trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07661836 on ClinicalTrials.gov ↗ ← All trials in Spain